Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis - PubMed (original) (raw)

Review

Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis

K R Bruckdorfer et al. Biochem Soc Trans. 1990 Dec.

No abstract available

PubMed Disclaimer

Similar articles

• Oxidized lipoproteins and nitric oxide.
  Jessup W. Jessup W. Curr Opin Lipidol. 1996 Oct;7(5):274-80. doi: 10.1097/00041433-199610000-00003. Curr Opin Lipidol. 1996. PMID: 8937516 Review.
• Antioxidants, lipoprotein oxidation, and arterial function.
  Bruckdorfer KR. Bruckdorfer KR. Lipids. 1996 Mar;31 Suppl:S83-5. doi: 10.1007/BF02637056. Lipids. 1996. PMID: 8729099 Review.
• [Possible mechanisms of inhibitory effects of atherosclerosis and lipoproteins on EDRF].
  Hirata K, Akita H, Inoue N, Matsuda Y, Yokoyama M. Hirata K, et al. Jpn Circ J. 1992;56 Suppl 5:1308-13. doi: 10.1253/jcj.56.supplementv_1308. Jpn Circ J. 1992. PMID: 1291714 Japanese. No abstract available.
• Iron and LDL-oxidation in atherogenesis.
  Yuan XM, Brunk UT. Yuan XM, et al. APMIS. 1998 Sep;106(9):825-42. doi: 10.1111/j.1699-0463.1998.tb00229.x. APMIS. 1998. PMID: 9808409 Review.
• Oxidation of LDL by nitric oxide and its modification by superoxides in macrophage and cell-free systems.
  Wang JM, Chow SN, Lin JK. Wang JM, et al. FEBS Lett. 1994 Apr 4;342(2):171-5. doi: 10.1016/0014-5793(94)80494-x. FEBS Lett. 1994. PMID: 8143872

Cited by

• Effects of single and multiple sessions of lower body diastole-synchronized compressions using a pulsating pneumatic suit on endothelium function and metabolic parameters in patients with type 2 diabetes: two controlled cross-over studies.
  Valensi P, Barber-Chamoux N, Rezki A, Lambert C, Pereira B, Dualé C, Delmas D, Duclos M. Valensi P, et al. Cardiovasc Diabetol. 2022 Dec 22;21(1):286. doi: 10.1186/s12933-022-01710-6. Cardiovasc Diabetol. 2022. PMID: 36550568 Free PMC article.
• Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial.
  Dashtabi A, Mazloom Z, Fararouei M, Hejazi N. Dashtabi A, et al. Res Cardiovasc Med. 2015 Dec 29;5(1):e29419. doi: 10.5812/cardiovascmed.29419. eCollection 2016 Feb. Res Cardiovasc Med. 2015. PMID: 26889456 Free PMC article.
• Endothelial dysfunction in type 2 diabetes.
  Natali A, Ferrannini E. Natali A, et al. Diabetologia. 2012 Jun;55(6):1559-63. doi: 10.1007/s00125-011-2445-5. Epub 2012 Jan 20. Diabetologia. 2012. PMID: 22261897
• Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
  Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Steinberg HO, et al. J Clin Invest. 1996 Jun 1;97(11):2601-10. doi: 10.1172/JCI118709. J Clin Invest. 1996. PMID: 8647954 Free PMC article.
• Drug antioxidant effects. A basis for drug selection?
  Halliwell B. Halliwell B. Drugs. 1991 Oct;42(4):569-605. doi: 10.2165/00003495-199142040-00003. Drugs. 1991. PMID: 1723362 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems